Compare

Enlivex Ltd. vs Core Scientific, Inc./tx vs Sharplink, Inc. vs Hyperliquid Strategies Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearEnlivex Ltd.
ENLV
Core Scientific, Inc./tx
CORZ
Sharplink, Inc.
SBET
Hyperliquid Strategies Inc
PURRRevenue covers only part of its income (partial revenue)
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenuen/a$319.02M$28.05Mn/a
Revenue growth (YoY)n/a-37.5%+666.1%n/a
Gross marginn/a11.9%n/an/a
Operating marginn/a-77.0%n/mn/a
Net marginn/a-90.5%n/mn/a
Net income$1.24B-$288.62M-$734.59M$305.54M
EPS (Diluted)$25.48-$0.88-$7.37$3.21
Operating cash flow-$10.42M$278.25M-$17.54M-$19.15M
Free cash flow-$10.48M-$450.75M-$17.55Mn/a
Cash & equivalents$1.89M$311.38Mn/a$137.92M
Total assets$2.33B$2.35B$2.43B$2.06B
Total liabilities$392.05M$3.31B$12.75M$187.14M
Shareholders' equity$1.93B-$962.74M$2.42B$1.87B
Return on year-end equity63.9%n/a-30.4%16.3%
Shares outstanding237.38M314.23M196.70M200.55M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearEnlivex Ltd.Core Scientific, Inc./txSharplink, Inc.Hyperliquid Strategies Inc
Latestn/a$319.02M
Ended 2025-12-31
$28.05M
Ended 2025-12-31
n/a
1 year earliern/a$510.67M
Ended 2024-12-31
$3.66M
Ended 2024-12-31
n/a
2 years earliern/a$502.40M
Ended 2023-12-31
$4.95M
Ended 2023-12-31
n/a
3 years earliern/a$640.31M
Ended 2022-12-31
$3.49M
Ended 2022-12-31
n/a
4 years earliern/a$544.48M
Ended 2021-12-31
n/an/a